Cav2.2 channel inhibitors (UCB)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCav2.2 channel inhibitors (UCB)
Drug Alias NameCav2.2 channel inhibitors (Lectus)N-type calcium channel blockers (UCB)N-type calcium channel blockers (Lectus)LTL-91154LTL-77157 +[7] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated N-type calcium channel alpha-1B subunit blockers
TargetsVoltage-gated N-type calcium channel alpha-1B subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLectus Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLectus Therapeutics LtdUcb Sa
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A